- Home
- Publications
- Publication Search
- Publication Details
Title
Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-08
DOI
10.3389/fonc.2021.680834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ROR1 targeting with the antibody drug-conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models
- (2021) Tiziana Vaisitti et al. BLOOD
- The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
- (2021) Kerstin Menck et al. Cells
- Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF‐1α regulator
- (2021) Hisanori Isomura et al. CANCER SCIENCE
- Role of noncanonical Wnt ligands and Ror‐family receptor tyrosine kinases in the development, regeneration, and diseases of the musculoskeletal system
- (2020) Koki Kamizaki et al. DEVELOPMENTAL DYNAMICS
- Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases
- (2020) Joshua B. Sheetz et al. MOLECULAR CELL
- Nuclear Regulation of Wnt/β-Catenin Signaling: It’s a Complex Situation
- (2020) Christin C. Anthony et al. Genes
- ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
- (2020) Amineh Ghaderi et al. Biomedicines
- Inhibition of HSP90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
- (2020) Behnoush Khaledian et al. CANCER SCIENCE
- WNT Signaling in Hematological Malignancies
- (2020) Michela Frenquelli et al. Frontiers in Oncology
- Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting
- (2019) Hanna Karvonen et al. ONCOGENE
- Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
- (2019) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucocorticoids promote breast cancer metastasis
- (2019) Milan M. S. Obradović et al. NATURE
- Novel ROR1 Inhibitor ARI-1 Suppresses the Development of Non-Small Cell Lung Cancer
- (2019) Xuesha Liu et al. CANCER LETTERS
- Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
- (2019) Norman Fultang et al. PLoS One
- Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia
- (2019) Yun Chen et al. BLOOD
- A fully chimeric IgG antibody for ROR1 suppresses ovarian cancer growth in vitro and in vivo
- (2019) Zhengna Yin et al. BIOMEDICINE & PHARMACOTHERAPY
- Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia
- (2018) Md Kamrul Hasan et al. BLOOD
- Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
- (2018) Michael Y. Choi et al. Cell Stem Cell
- ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
- (2018) C.E. Henry et al. GYNECOLOGIC ONCOLOGY
- First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells
- (2018) M. Hojjat-Farsangi et al. LEUKEMIA
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib
- (2018) Amir Hossein Daneshmanesh et al. PLoS One
- Cirmtuzumab inhibits ibrutinib-resistant, Wnt5a-induced Rac1 activation and proliferation in mantle cell lymphoma
- (2018) Jian Yu et al. Oncotarget
- ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer
- (2018) Gui‑Li Xu et al. Molecular Medicine Reports
- Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
- (2018) Juho Heliste et al. BMC Cardiovascular Disorders
- Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells
- (2018) Md Kamrul Hasan et al. LEUKEMIA
- Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells
- (2017) J Yu et al. LEUKEMIA
- Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
- (2017) M K Hasan et al. LEUKEMIA
- A ROR1–HER3–lncRNA signalling axis modulates the Hippo–YAP pathway to regulate bone metastasis
- (2017) Chunlai Li et al. NATURE CELL BIOLOGY
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Planar cell polarity in development and disease
- (2017) Mitchell T. Butler et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer
- (2017) Jian-Kang Zhou et al. Oncotarget
- Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells
- (2017) Zhengna Yin et al. Oncotarget
- An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors
- (2017) Satyen Harish Gohil et al. OncoImmunology
- Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies
- (2017) Leili Aghebati-Maleki et al. SLAS Discovery
- High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
- (2016) B. Cui et al. BLOOD
- Receptor tyrosine kinase-like orphan receptor 1, a target ofNKX2-1/TTF-1lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma
- (2016) Lisa Ida et al. CANCER SCIENCE
- Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues
- (2016) Ashwini Balakrishnan et al. CLINICAL CANCER RESEARCH
- ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1
- (2016) Tomoya Yamaguchi et al. Nature Communications
- ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
- (2016) Yu-Zhu Zheng et al. Scientific Reports
- Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia
- (2015) P. Janovska et al. CLINICAL CANCER RESEARCH
- ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo
- (2015) Rajeswaran Mani et al. EXPERIMENTAL HEMATOLOGY
- Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
- (2015) Jian Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer
- (2015) Jinqiu Tao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway
- (2015) Natalia Brenda Fernández et al. MOLECULAR CARCINOGENESIS
- The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells
- (2014) Alessandra Gentile et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia
- (2014) R Mani et al. LEUKEMIA
- Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
- (2014) Travis W. Bainbridge et al. PLoS One
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROR1, an embryonic protein with an emerging role in cancer biology
- (2014) Nicholas Borcherding et al. Protein & Cell
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia
- (2012) Vincent T. Bicocca et al. CANCER CELL
- NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
- (2012) Tomoya Yamaguchi et al. CANCER CELL
- Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
- (2012) A H Daneshmanesh et al. LEUKEMIA
- Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures
- (2012) Therese Högfeldt et al. LEUKEMIA & LYMPHOMA
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- TCF/LEFs and Wnt Signaling in the Nucleus
- (2012) K. M. Cadigan et al. Cold Spring Harbor Perspectives in Biology
- Wnt/Ca2+ signaling pathway: a brief overview
- (2011) Antara De ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
- (2011) A. Gentile et al. CANCER RESEARCH
- ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia
- (2011) H. Elizabeth Broome et al. LEUKEMIA RESEARCH
- Mouse Resistin Modulates Adipogenesis and Glucose Uptake in 3T3-L1 Preadipocytes Through the ROR1 Receptor
- (2011) Beatriz Sánchez-Solana et al. MOLECULAR ENDOCRINOLOGY
- Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
- (2011) Jiahui Yang et al. PLoS One
- Wnt5a/Ror2-induced upregulation of xPAPC requires xShcA
- (2010) Ann Caroline Feike et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
- (2010) M. Hudecek et al. BLOOD
- ROR1 expression is not a unique marker of CLL
- (2010) Gábor Barna et al. HEMATOLOGICAL ONCOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
- (2009) Amanda Mikels et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase
- (2008) Yan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Deleted in Brachydactyly B Domain of ROR2 Is Required for Receptor Activation by Recruitment of Src
- (2008) Shiva Akbarzadeh et al. PLoS One
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a
- (2008) T. Fukuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now